體外式薄膜型人工肺(ECMO)市場:各市場區隔規模，佔有率，趨勢與SWOT分析，法規與償付狀況，手術，預測，2015年∼2030年

本報告提供全球體外式薄膜型人工肺(ECMO)市場相關調查，提供市場概要，以及2015年∼2030年的市場預測，各市場區隔趨勢，SWOT分析，COVID-19影響，市場上競爭情形等資訊。

目錄

• 現在上市的體外式薄膜型人工肺(ECMO)及不斷變化的競爭環境
• 主要的產業趨勢洞察
• 體外式薄膜型人工肺(ECMO)各市場區隔年度總銷售額和2015年∼2030年的市場展望
• 有關各市場區隔的整體手術數，單位，平均銷售價格，市場價值的詳細資料
• 地區，各國洞察
• 市場SWOT分析

對象企業

• Getinge USA Inc(MAQUET)
• Abbott Laboratories
• Terumo Corp
• Medtronic plc
• LivaNova plc(Sorin Group)
• MicroPort Scientific Corporation
• Eurosets Srl，OriGen Biomedical Inc
• Fresenius SE &Co KGaA
• ALung Technologies Inc
• 其他

Extracorporeal Membrane Oxygenation (ECMO) Devices (Cardiovascular) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Extracorporeal Membrane Oxygenation (ECMO) Devices market for the year 2020 and beyond. Extracorporeal Membrane Oxygenation Devices are used to treat Myocardial Infraction, Heart Failure, Cardiogenic Shock, Congenital Heart Disease and Acute Respiratory Distress Syndrome. Such patients develop the inability to properly oxygenate their blood, due to complications of the lung, heart or both. Venous Cannulae are inserted into the jugular vein or the femoral vein to drain venous blood from the superior/inferior vena cava, and returning oxygenated blood to the right atrium. Arterial cannulae are inserted into the aortic artery or the femoral artery to bypass the heart and lungs and return oxygenated blood into the arterial system from the ECMO machine. Oxygenators are used to replace the role of lungs by removing CO2 and oxygenating venous blood prior to being returned to the heart or arterial system. Pumps are used to manage the drainage of venous blood, flow rate through the oxygenator, and flow rate for returning oxygenated blood.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Extracorporeal Membrane Oxygenation (ECMO) Devices market and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Extracorporeal Membrane Oxygenation (ECMO) Devices market revenue by segment and market outlooks from 2015-2030.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Extracorporeal Membrane Oxygenation (ECMO) Devices market.
• Competitive dynamics insights and trends provided Extracorporeal Membrane Oxygenation (ECMO) Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Getinge USA Inc (MAQUET), Abbott Laboratories, Terumo Corp , Medtronic plc, LivaNova plc (Sorin Group), MicroPort Scientific Corporation, Eurosets Srl , OriGen Biomedical Inc, Fresenius SE & Co KGaA, ALung Technologies Inc, Others

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the ECM0 marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on ECMO market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving ECMO market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the ECMO market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific ECMO market from 2015-2030.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.